Portada | Volúmenes anteriores

Ginecología y Obstetricia
© Sociedad Peruana de Obstetricia y Ginecología
 

Ginecol. Obstet. (Perú)     2003; 49 (1) : 53-58


INFECCIÓN POR PAPILOMAVIRUS HUMANO Y RIESGO INMUNOLÓGICO 
DE CÁNCER DE CUELLO UTERINO

 Jorge Cervantes
 

BIBLIOGRAFÍA

  1. Fraumeni JF Jr, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J Natl Cancer Inst 1969; 42(3): 455-68.

  1. Kessler II, KuIcar Z, Zimolo A, Grgurevic M, Strnad M, Goodwin BJ. Cervical cancer in Yugoslavia. II. Epidemiologic factors of possible etiologic significance. J Natl Cancer Inst 1974 Jul; 53(1):51-60.

  2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4335647&dopt=Abstract" Pridan H, Lilienfeld AM. Carcinoma of the cervix in jewish women in Israel, 1960-67. An epidemiological study. Isir J Med Sci 1971;7:1465-70.

  3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=202434&dopt=Abstract" zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 781-30.

  4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=202434&dopt=Abstrac" zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989; 49(17):4677-81.

  5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=202434&dopt=Abstract" zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.

  6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2983228&dopt=Abstract" Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Strem1au A, zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314(6006):111-4.

  7. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1654-8.

  8. Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, Lipetz C, Evans AS, Mason M. Clinical studies of human papilloma vaccines in preinvasive and invasive cancer. Vaccine 2001; 19:254956.

  9. Tjiong MY, Out TA, Ter Schegget J, Burger MP, Van Der Vange N. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review. Int J Gynecol Cancer 2001;l 1(1):9-17.

  10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2821311&dopt=Abstract" Lorincz AT, Temple GF, Kurman RJ Jenson AB, Lancaster WD. Oncogenic association of specific human papillomavirus types with cervical neoplasia.J Natl Cancer Inst 1987;79(4):671-7.

  11. Odunsi KO, Ganesan TS. The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer. Clin Oncol (R Coll Radiol) 1997;9(1):4-13.

  12. Ríos Dalenz J, CastroMD. Evaluación de la Situación del Cáncer de Cuello Uterino en Bolivia. Revisión Bibliográfica. OPS/OMS Ministerio de Salud Y Previsión Social Engender Health, Formerly AVSC Intemational. 2001.

  13. IARC(1998)Globocan l, Cancer incidence and Mortality Worldwide(IARC Cancer Base N03). International Agency for Research on Cancer:Lyon.

  14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=pubMed&l ist_uids=11095833&dopt=Abstract" Hagensee ME. Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment. Curr Infect Dis Rep2000; 2(1):18-24.

  15. zur Hausen H (1994). Human pathogenic papillomaviruses. In 'Molecular Pathogenesis of Cancer of the Cervix and its causation by specififc Human PapillomavirusTypes'. CurrenyTopics in Microbiology and Immunology CTMI186. Springer-Verlag, Berlin, Heidelberg, 1994, pp 131-56.

  16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11578388&dopt=Abstract" Gaarenstroom KN, Melkert P, Walboomers JM, Van Den Brule AJ, Van Bommel PF, Meyer CJ, Voorhorst FJ, Kenemans P, Helmerhorst TJ. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia.Int J Gynecol Cancer 1994;4(2):73-8.

  17. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79(3):328-37.

  18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1328880&dopt=Abstract" Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB.A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327(18):1272 -8.

  19. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, preventionand the role of human papillomavirus infection. ReviewArticle. Can Med Assoc Licensors CMAJ 2001; 164 (7); 1017-25.

  20. Chan PK, Li WH, Chan MY Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999;S9:232-8.

  21. Abstract" Chan R, Khoo L, Ho TH, Koh CF Lee IW, Yam KL, Chandra D, Pang M, Chow V. A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J Std AIDS 2001; 2(3):159-63.

  22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10895031 &dopt=Abstract" Wong YF, Chung TK, Cheung TH, Nobori T, Hampton GM, Wang VW, LiYF, Chang AM. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer. Gynecol Obstet Invest 2000;50:60-3

  23. Chichareon S, Herrero R, Muñoz N, Bosch FX, jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90(1):50-7

  24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11205488&dopt=Abstract" Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese wornen. Cancer Epidemiol Biomarkers Prev 2001; 10(1):45-52.

  25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10642935&dopt=Abstract"HwangT.Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999;14(6):593-9.

  26. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwicde perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87(11):796-802.

  27. cgi-cmd=Retrieve&db=PubMed&list_uids=11169968&dopt=Abstract" Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P, Hernández P, Salmeron J, Hernández M. Epiderniology of HPV infection among Mexican wornen with normal cervical cytology. Int J Cancer. 2001 Feb 1;91 (3):412-20.

  28. Lema CH, Hurtado LV, Segurondo D, Romero F, Dulon A, Asturizaga D, Panoso W, García G, Fujiyoshi T, Yashiki S, Li LIC, Lou H, Cervantes J, Hurtado L et Sonoda S. Human Papillomavirus Infection among Bolivian Amazonian Women. Asian Pacific J Cancer Prevention 2001; 2:135-41.

  29. Santos C, Muñoz N, Klug S, Almonte M, Guerrero L, Álvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer C, Cáceres E. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001; 85:966-71.

  30. Ong C-K, Bernard H-U, Villa LL. Identification of Genomic Sequences of Three Novel Human Papillomavirus Sequences in Cervical Smears of Amazonian Indians. J Infect Dis 1994; 170:1086-8.

  31. Bernard HU, Chan SY, Manos MM et al Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction, restriction fragment length polymorphism, nucleotide sequence and phylogenetic algorithms. J Infect Dis 1994; 70:1077-85.

  32. Silins I, Wang Z, Avall-Lundqvist E, Frankendal B, Vikmanis U, Sapp M, Schiller JT, Dillner J. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol 1999;80 (Pt 11):2931-6.)

  33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11919208&dopt=Abstract" Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.

  34. Terris MK, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 1997;50(1):150-6.

  35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1851805&dopt=Abstract" Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato l, Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991;72 (Pt 5): 103 9-44.

  36. Bryant, Neville J. The HLA system in An Introduction to Immunohematology. Third Edition 1994.W.B. Saunders Company.pp 256-73.

  37. Apple RJ, Erlich HA. HLA class II genes: structure and diversity, in HLA and MHC: genes, molecules and function. Edited by M. Browning and A. McMichael. BIOS Scientific Publishers Limited, 1996 pp97-112.

  38. T" Moss DJ, Khanna R. Major histocompatibility complex: from genes to function. Immunol Today 1999;20(4):165-7.

  39. Cuzick J, Terry G, Ho G, Monaghan J, Lopes A, Clarkson P, Duncan L. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 2000; 82(7): 1348-52.

  40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8106758&dopt=Abstract" Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994 Feb; 69(2):23540.

  41. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338(7):423-8.

  42. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986 Aug;68(2):251-8.

  43. 72&dopt=Abstract"Schneider V, Kay S, Lee HM. Immunosuppression as a high-risk factor in the development of condylorna acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983;27(3):220-4.

  44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=393355&dopt=Abstract" Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979;2(6203):1461-6.

  45. Koss LG. Cytologic and histologic manifestations of human papillomavirus infection of the female genital tract and their clinical significance. Cancer 1987 Oct 15;60(8 Suppl):1 942-50.

  46. Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, Schiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 1999 jul 30;82(3):334-7.

  47. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10037100&dopt=Abstract" Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, García P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)positive and high risk HIV-negative women. J Natl Cancer Inst 1999 Feb 3;9](3):226-36.

  48. Krul EJ, Schipper GM, Schreuder GJ, Fleuren, GG Kenter, Melief JM. HLA and Susceptibility to Cervical Neoplasia. Hum Immunol 1999; 60, 337-342.

  49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10885560&dopt=Abstract" Brady CS, Bartholomew JS, Burt DJ, Duggan-Keen MF, Glenville S, Telford N, Little AM, Davidson JA, Jiménez P, Ruiz-Cabello F, Garrido F, Stern PL. Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens 2000 May; 55(5):401 -11.

  50. Tabrizi SN, Fairley CK, Chen S, Borg AJ, Baghurst P, Quinn MA, Garland SM. Epidemiological characteristics of women with high grade CIN who do and do not have human papillomavirus. Br J Obstet Gynaecol. 1999 Mar 106(3):252-7.

  51. Apple RJ, Lin P, Becker TM, Erlich HA, Wheeler CM. Both HLA-B7 and DRBI *l501 appear to be required to confer risk to HPV-16 associated invasive cancer, but function as independent risk factors for HPV 16associated severe displasia. In : Genetic diversity of HLA. Functional and Medical Implication.Volume l. pp758760 Dominique Charron, Editor EDK Medical and Scientific International Publisher. 1997.

  52. Mehal WZ, Lo YM, Herrington CS, Evans MF, Papadopoulos MC, Odunis K, Ganesan TS, McGee JO, Bell JL, Fleming KA. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J Clin Pathol 1994 Dec;47(12):1077-81.

  53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10374768&dopt=Abstract" Silva B, Vargas-Alarcon G, Zuñiga-Ramos J, Rodríguez-ReynaTS, Hernández-Martínez B, Osnaya N, Kofman S, Torres Lobatón A, Granados J. Genetic features of Mexican women predisposing to cancer of the uterine cervix. Hum Pathol 1999 jun;30(6):626-8.

  54. Cervantes J, Hurtado LV, lema C, Andrade R, Hurtado L, Yashiki S, Fujiyoshi T, Sonoda S. HLA-DRB1*l602 allele association with HPV infection in Bolivian women. Tissue Antigens 2002 59(2) :122 P32.12.

  55. Lawson HW, Lee NC, Thames SF, Henson R, Miller DS. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.Obstet Gynecol. 1998 Nov;92(5):74552.

  56. Kenney JW. Ethnic differences in risk factor sassociated with genital human papillomavirus infections J. Adv Nurs 1996 jun;23(6):1221-7.

  57. Becker TM, Wheeler CM, Key CR, Samet JM. Cervical cancer incidence and mortality in New Mexico´s Hispanics, American Indians, and nonHispanic whites. West J Med 1992 Apr; 56(4):376-9,


Texto completo | Tabla de contenido

Volúmenes anteriores | Listado por Títulos


UNMSM | Sistema de Bibliotecas | Biblioteca Digital

© 1997-2008 UNMSM. Oficina General del Sistema de Bibliotecas y Biblioteca Central
Comentarios y/o sugerencia : sisbiblio@unmsm.edu.pe
Todos los derechos reservados
Lima - Perú